The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Material Transfer & Cooperation Agreement

13 Jun 2022 07:30

RNS Number : 6077O
Quadrise Fuels International PLC
13 June 2022
 

13 June 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Material Transfer & Cooperation Agreement

Further to the announcement on 9 May 2022, Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, is pleased to announce it has signed a new Material Transfer & Cooperation Agreement (the "Agreement") with its client in Morocco (the "Client"). This Agreement supersedes the original agreement with the Client, announced on 29 November 2019.

Under the terms of the Agreement, Quadrise will manufacture trial quantities of MSAR® and bioMSAR™ for the purpose of an industrial demonstration test at one of the Client's sites. Quadrise will then provide the Client with a written report on the efficacy of using MSAR® and bioMSAR™. Provided the Client-specified deliverables regarding performance and product quality are met, the parties will enter into discussions for a potential commercial supply of MSAR® and/or bioMSAR™.

In parallel, Quadrise will also complete a technical and economic feasibility study for a potential additional industrial demonstration test at a second site of the Client. This study is close to completion, pending a final visit to the second site by the Quadrise team. This additional industrial demonstration test will be subject to future agreement, once confirmed.

The industrial demonstration test and feasibility study covered by this Agreement will occur concurrently, with completion expected in Q3 2022.

The Agreement is valid for one year unless mutually extended.

Jason Miles, CEO of Quadrise, commented:

"We are advancing all of our projects to progress them towards commerciality. We are pleased that we have renewed our agreement with this key Client in Morocco. We are confident that we will be able to demonstrate the economic and environmental benefits of using MSAR® and bioMSAR™ at the Client's industrial site, and look forward to expediting the project."

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

Notes to Editors

 

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBKNBBABKKFAD
Date   Source Headline
31st Oct 20167:00 amRNSResult of Open Offer
28th Oct 201611:53 amRNSHolding(s) in Company
26th Oct 20164:46 pmRNSHolding(s) in Company & Director/PDMR Shareholding
18th Oct 20167:00 amRNSNew Corporate Website
14th Oct 20167:00 amRNSOpen Offer
12th Oct 20162:46 pmRNSResults of Placing
12th Oct 20167:01 amRNSProposed Placing and Proposed Open Offer
12th Oct 20167:00 amRNSFinal Results
30th Sep 20167:00 amRNSOperational Update
14th Sep 20167:00 amRNSExtension of Contracts with AkzoNobel
11th Aug 20165:20 pmRNSHolding(s) in Company
10th Aug 20168:43 amRNSMemorandum of Understanding
21st Jul 20167:00 amRNSDirectorate Change
12th Jul 20164:24 pmRNSDirector/PDMR Shareholding
5th Jul 20162:05 pmRNSDirector/PDMR Shareholding
5th Jul 20167:00 amRNSEnd of Year Update
28th Jun 20163:09 pmRNSHolding(s) in Company
13th Jun 20164:40 pmRNSSecond Price Monitoring Extn
13th Jun 20164:35 pmRNSPrice Monitoring Extension
10th Jun 20164:40 pmRNSSecond Price Monitoring Extn
10th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Apr 20165:11 pmRNSIssue of Options and Director's Dealing
1st Apr 20167:00 amRNSFurther re Directorate Change
24th Mar 20164:13 pmRNSIssue of Options and Directors' Dealings
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 20163:04 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSHalf Yearly Report
17th Mar 20161:11 pmRNSMarine Programme Update
3rd Mar 20164:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:13 pmRNSNotice of Interim Results
2nd Feb 20167:00 amRNSDirectorate Change
21st Dec 20152:24 pmRNSDirector/PDMR Shareholding
17th Dec 20154:40 pmRNSSecond Price Monitoring Extn
17th Dec 20154:35 pmRNSPrice Monitoring Extension
14th Dec 20152:23 pmRNSFeasibility Study Contract
27th Nov 20154:16 pmRNSResult of AGM
23rd Nov 20157:00 amRNSDirectorate Change
19th Nov 20157:00 amRNSUpdate re Research & Development Programmes
4th Nov 20154:47 pmRNSPosting of Annual Report and Notice of AGM
2nd Nov 20154:35 pmRNSPrice Monitoring Extension
15th Oct 20154:40 pmRNSSecond Price Monitoring Extn
15th Oct 20154:35 pmRNSPrice Monitoring Extension
12th Oct 20157:00 amRNSFinal Results
1st Oct 20155:38 pmRNSHolding(s) in Company
16th Sep 20157:00 amRNSHalf Year Update on Major Active Programmes
25th Aug 20154:41 pmRNSSecond Price Monitoring Extn
25th Aug 20154:35 pmRNSPrice Monitoring Extension
13th Aug 20154:35 pmRNSPrice Monitoring Extension
12th Aug 20154:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.